Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — Novozymes — Q1 2020 Earnings Presentation
11 slides from Novonesis A/s Class B's earnings presentation, Apr 29, 2020
Slide 1: Conference call Q1 2020
Conference call Qi 2020 April 29, 2020 Rethink Tomorrow 2 = nhovozymes:
Slide 2: Disclaimer
Disclaimer Forward Looking Statement This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limite
Slide 3: Highlights
Highlights Strong first quarter; 2020 Outlook remains suspended 1.2020 12019 Realized Realized * Strong sales across all main business segments and geographies Sales growth, organic % 10 4 + Agile organization able to meet demand despite COVID-19 disruptions EBIT margin % 28.9 25.7 ROIC incl. goodwi
Slide 4: Organic sales growth by geography
Organic sales growth by geography with main markets Europe, Middle East © Wain sites wth production and R&D © Satelite production site @ Satelite RAD site North America & Africa Qty: Qty: 9 8% 10% 38 % of sales of sales e Latin America Asia Pacific Ql y/y: Ql y/y [e) 27% 4% 19 %o of sales of sales E
Slide 5: Household Care
Latest results Household Care oe ) Strong start amplified by COVID-19 effects * Organic sales; Q1 y/y: +11% 11% + New Freshness solution for liquid and unit dose detergents made available Q 5% * COVID-19 related stockpiling, pantry loading and 1% 1% increased at-home usage . 3% 2020 perspectives Qvi
Slide 6: Food & Beverages
Latest results Food & Beverages Strong start led by baking Organic sales; Q1 y/y: +11% Strong growth in baking, beverages and grains; food & nutrition slightly down Saphera Fiber® — increasing fiber and sweetness with no added sugar Sales likely affected by COVID-19 related demand 2020 perspectives
Slide 7: Bioenergy
Latest results Bioenergy Strong Q1 performance Organic sales; Q1 y/y: +11% Performance driven by Brazil, yeast and growth in US production volumes “Stay-at-home’ orders led to double-digit drop in US gasoline and ethanol demand in last week of March 2020 perspectives COVID-19 implications continue t
Slide 8: Agriculture & Feed
Latest results Agriculture & Feed Good start to the year Organic sales; Q14 y/y: +8% Growth in both BioAg and Feed BioAg transitioning well to new set-up TAEGRO® - biocontrol solution for fruit and vegetables 2020 perspectives Continued penetration with Balancius™ and bioinoculants for corn Global f
Slide 9: Financials
Financials Strong financial performance as top line growth emphasizes operational leverage * Organic sales; Q1 y/y: +10% * Gross margin at 57.1% - 160bps higher than last year driven by improved production efficiency, higher operational leverage and lower input costs + EBIT margin at 28.9% - 320bps
Slide 10: Quarterly summary
Quarterly summary Strong first quarter performance, but outlook suspended + Novozymes is clearly geared to deliver * Strong sales and financial performance despite COVID-19 disruptions * Outlook remains suspended as uncertainty persists especially concerning US ethanol demand and stockpiling effects
Slide 11: Slide 11